Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Vergo Pharma Research Laboratories
Location
T. Score
Peers
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED

www.vergolabs.com

Active

Updated: 07 Oct 2024

Vergo Pharma Research Laboratories Private Limited, is an unlisted private company incorporated on 10 August, 2010. It is classified as a private limited company and is located in Panaji, Goa. It's authorized share capital is INR 27.00 cr and the total paid-up capital is INR 27.00 cr.

Vergo Pharma Research Laboratories's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 1392.09% over the previous year.

Industry

Research and Development

Products

Cytotoxic Laboratory, Analytical Development, Formulation Development, Regulatory Support, High Potency Product Development, Clinical Batch Manufacturing, Clinical BA/BE Studies., Clinical Research, Stability Studies

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

14.2%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

₹ GET PRO

Networth

₹ GET PRO

Borrowings

-1.64%

₹ GET PRO

Assets

2.27%

₹ GET PRO

Gross Margin

4.16

GET PRO %

Operating Margin

16.18

GET PRO %

Net Profit Margin

18.62

GET PRO %

Return on Equity

GET PRO %

ROCE

14.96

GET PRO %

Debt to Equity

-0.22

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (2)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Clearsynth Labs Limited Maharashtra

Nuray Chemicals Private Limited Tamil Nadu

Nifty Labs Private Limited Telangana

Peers

Clearsynth Labs Limited

Maharashtra

Nuray Chemicals Private Limited

Tamil Nadu

Nifty Labs Private Limited

Telangana

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	25.0	27.0	27.0	27.0	27.0
Reserves	-57.5	-50.5	-52.3	-53.8	-47.5
Borrowings +	108.1	112.5	131.7	140.4	138.3
Long term borrowings	106.5	103.1	108.4	121.9	117.8
Short term borrowings	1.6	9.4	23.3	18.6	20.4
Trade payables +	5.2	4.3	7.5	5.3	5.4
Days payable	106.0	109.0	107.0	47.0	45.0
Other liabilities +	12.4	17.8	23.6	24.0	23.9
Other non-current liabilities	1.9	2.7	3.0	2.9	2.8
Other current liabilities	5.3	10.8	13.1	15.7	15.7
Total liabilities	88.0	106.8	130.0	137.6	141.6
Fixed Assets +	58.8	63.0	73.2	81.6	77.0
Tangible assets	29.7	26.8	26.0	39.5	34.8
CWIP	7.8	15.3	26.3	21.4	20.4
Intangible assets	21.2	21.0	20.9	20.8	21.8
LT loans and advances	-	-	-	-	-
Other non-current assets	2.7	2.8	2.6	1.7	2.7
Current assets +	26.5	41.0	54.2	54.2	61.8
Inventories	4.3	7.6	10.9	14.1	13.8
Trade receivables	5.9	11.3	19.3	16.4	26.5
Cash and cash equivalents	0.4	4.8	1.5	0.8	0.5
ST loans and advances	-	-	-	-	-
Other current assets	15.9	17.3	22.4	22.9	21.0
Total assets	88.0	106.8	130.0	137.6	141.6

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	28.42	25.28	20.77	19.62	19.07
Reserves	-65.42	-47.29	-40.23	-39.08	-33.57
Borrowings +	122.92	105.31	101.29	102.04	97.64
Long term borrowings	121.08	96.55	83.36	88.55	83.21
Short term borrowings	1.84	8.76	17.94	13.49	14.43
Trade payables	5.86	4.01	5.76	3.89	3.8
Other liabilities +	14.08	16.7	18.17	17.42	16.86
Other non-current liabilities	2.18	2.55	2.32	2.11	1.95
Other current liabilities	6.03	10.13	10.09	11.42	11.11
Total liabilities
Fixed Assets +	66.81	58.98	56.33	59.32	54.39
Tangible assets	33.79	25.05	20.01	28.67	24.6
CWIP	8.88	14.29	20.24	15.57	14.42
Intangible assets	24.14	19.63	16.08	15.08	15.37
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	3.12	2.65	1.99	1.27	1.94
Current assets +	30.07	38.37	41.68	39.41	43.67
Inventories	4.84	7.08	8.41	10.27	9.77
Trade receivables	6.71	10.62	14.82	11.91	18.73
Cash and cash equivalents	0.48	4.5	1.18	0.58	0.34
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	18.04	16.17	17.26	16.65	14.83
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	56.6	57.4	67.7	91.0	99.6
Sales growth %	41.72	1.48	17.94	34.4	9.47
Expenses +	57.0	55.8	69.7	92.8	95.3
Cost of goods	17.7	14.4	25.4	41.7	43.8
Employee cost	19.6	22.6	24.1	25.3	23.3
Other costs	14.4	13.6	15.2	18.9	20.7
Operating profit +	4.9	6.8	3.0	5.1	11.8
Operating margin %	8.6	11.9	4.4	5.6	11.9
Other income	0.7	1.0	0.2	0.4	1.3
Interest	0.2	0.3	0.8	2.2	2.1
Depreciation	5.1	4.9	4.2	4.7	5.4
Exceptional items	-	-	-	-	-
Profit before tax	0.2	2.6	-1.8	-1.4	5.6
Tax	-	-	-	-	-0.6
Profit - disc. ops	-	-	-	-	-
Net profit	0.2	2.5	-1.8	-1.5	6.2
Net margin %	0.3	4.4	-2.7	-1.6	6.2

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	98.76	98.36	99.69	99.56	98.7
Expenses +	99.57	95.58	102.66	101.56	94.45
Cost of goods	30.94	24.62	37.44	45.57	43.41
Employee cost	34.27	38.71	35.45	27.69	23.07
Other costs	25.07	23.32	22.42	20.7	20.49
Operating profit	8.47	11.71	4.37	5.6	11.73
Other income	1.24	1.64	0.31	0.44	1.3
Interest	0.31	0.59	1.23	2.41	2.13
Depreciation	8.96	8.34	6.12	5.19	5.35
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.43	4.42	-2.66	-1.56	5.55
Tax	0.09	0.06	0.0	0.05	-0.62
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	0.34	4.36	-2.66	-1.6	6.18

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	-3.3	-4.8	-5.2	-5.2	-6.7
Net Debt/Equity	-3.3	-4.6	-5.1	-5.2	-6.7
Total Debt/Assets	1.2	1.1	1.0	1.0	1.0
Total Assets/Equity	-2.7	-4.5	-5.1	-5.1	-6.9
Liquidity +
Current Ratio	2.2	1.7	1.2	1.4	1.5
Quick Ratio	1.8	1.4	1.0	1.0	1.2
Interest Coverage	27.0	19.7	3.6	2.3	5.5
Performance
Gross Margin	68.7	75.0	62.4	54.2	56.0
Operating Margin	8.6	11.9	4.4	5.6	11.9
Net Margin	0.3	4.4	-2.7	-1.6	6.2
Return +
Return on Equity	-	-	-	-	-
Pre-tax ROCE	-0.4	2.5	-1.4	0.4	6.6
Return on Assets	0.2	2.4	-1.4	-1.1	4.4
Pre-tax ROIC	-0.4	2.3	-1.1	0.3	5.5
Efficiency +
Days Payable	106.0	109.0	107.0	47.0	45.0
Days Inventory	88.0	192.0	157.0	124.0	115.0
Days Receivable	38.0	72.0	104.0	66.0	97.0
Fixed Asset Turnover	1.0	0.9	0.9	1.1	1.3
Total Asset Turnover	0.6	0.5	0.5	0.7	0.7
Working Capital
Cash Conversion Cycle	20.0	155.0	154.0	143.0	167.0
Working Capital Days	93.0	105.0	55.0	59.0	74.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

ICICI Bank Limited

No. of Loans: 2

Total Amount : 28.0 cr

Charge Holder	Amount	Date of creation/modification
ICICI Bank Limited	10.0 cr	30 Jul, 2022
ICICI Bank Limited	18.0 cr	30 Jul, 2022

Charges

ICICI Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Prasad Vassudev Keni Shareholder	00841272	15 years
Director	Vini Prasad Keni Shareholder	00841316	15 years
Director	Praveen Khullar	08304372	3 years
Director	Kashyap Prasad Keni	08566931	6 years
Kmp	Rajiv . Mundhra	<HIDDEN>	2 years
CS	Pouras Narahari Rane	<HIDDEN>	6 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
VERGO PHARMA RESEARCH PRIVATE LIMITED	Active	1.0 L	4	Goa
VILMAN HEALTHCARE PRIVATE LIMITED	Active	10.0 L	3	Goa
VERGO ORGANICS PRIVATE LIMITED	Strike Off	1.0 L	2	Goa
V.G. QUENIM MINING PRIVATE LIMITED.	Active	1.0 L	3	Goa
INTEGRINA TECHNOLOGIES PRIVATE LIMITED	Active	3.5 Cr	1	Goa
SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED	Amalgamated	33.4 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
VERGO PHARMA RESEARCH PRIVATE LIMITED	Goa	2010	₹ 1.0 L

Registered Details

CIN

U73200GA2010PTC006462

PAN

AADCV3673Q

Incorporation

2010, 14.8 years

Company Email

pouras.rane@vergolabs.com

Paid up Capital

₹ 27.0 Cr

Authorised Capital

₹ 27.0 Cr

AGM

Sep 2023

Type

Private

Non-government Company

FAQ - VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED

What is the incorporation date of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED?

The incorporation date of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED is 10 August, 2010

What is the authorized share capital of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED?

The authorized share capital of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED is INR ₹ 27.0 Cr.

What is the paid-up capital of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED?

The paid-up capital of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED is INR ₹ 27.0 Cr.

What is the registered address of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED?

The registered address of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED is KENI BUILDING DR. DADA VAIDYA ROAD PANAJI Goa - 403001

What is the CIN number of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED?

The CIN number of VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED is U73200GA2010PTC006462.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Peers / Similar Companies

Peers

Clearsynth Labs Limited

Nuray Chemicals Private Limited

Nifty Labs Private Limited

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network